SEIKAGAKU BIOBUSINESS Trademark

Trademark Overview


On Friday, March 13, 2009, a trademark application was filed for SEIKAGAKU BIOBUSINESS with the United States Patent and Trademark Office. The USPTO has given the SEIKAGAKU BIOBUSINESS trademark a serial number of 79071476. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 14, 2019. This trademark is owned by SEIKAGAKU CORPORATION. The SEIKAGAKU BIOBUSINESS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Products & Electrical & Scientific Products categories with the following description:

Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins and beta-glucan; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents ...

Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes

Laboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, density meters, concentration meters; Laboratory apparatus and instruments for use in analyzing urine, namely, clinical laboratory analyzers for measuring, testing and analyzing urine; Laboratory apparatus and instruments, namely, chemical and biochemical analytical instruments in the nature of laboratory chemical reactors, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Electronic machines, apparatus and their parts, namely, clinical chemistry analyzers for labor...
seikagaku biobusiness

General Information


Serial Number79071476
Word MarkSEIKAGAKU BIOBUSINESS
Filing DateFriday, March 13, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 14, 2019
Registration Number4326258
Registration DateTuesday, April 30, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOBUSINESS"
Goods and ServicesHyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins and beta-glucan; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use
Goods and ServicesJoint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes
Goods and ServicesLaboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, density meters, concentration meters; Laboratory apparatus and instruments for use in analyzing urine, namely, clinical laboratory analyzers for measuring, testing and analyzing urine; Laboratory apparatus and instruments, namely, chemical and biochemical analytical instruments in the nature of laboratory chemical reactors, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Electronic machines, apparatus and their parts, namely, clinical chemistry analyzers for laboratory use in the analysis of biological samples; Magnetic media with recorded programs, namely, pre-recorded magnetic media featuring computer programs used to control and collect data from optical readers, and to analyze data and generate reports for use in the field of endotoxin and beta-glucan analysis
Pseudo MarkSEIKAGAKU BIO BUSINESS
Section 2(f) Limitation StatementAs to "SEIKAGAKU"
Translation of Words in MarkThe English translation of "SEIKAGAKU" in the mark is "BIOCHEMISTRY".

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 14, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 14, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEIKAGAKU CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSEIKAGAKU CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSEIKAGAKU CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, October 4, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 4, 2019DEATH OF INTERNATIONAL REGISTRATION
Monday, April 30, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 15, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 24, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 9, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 9, 2014FINAL DISPOSITION PROCESSED
Tuesday, July 30, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 30, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, March 3, 2013NOTIFICATION PROCESSED BY IB
Tuesday, February 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 23, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 4, 2013ASSIGNED TO LIE
Monday, December 31, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 15, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 16, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 16, 2012NON-FINAL ACTION E-MAILED
Saturday, June 16, 2012NON-FINAL ACTION WRITTEN
Wednesday, May 16, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 15, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 17, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2011NON-FINAL ACTION E-MAILED
Thursday, November 17, 2011NON-FINAL ACTION WRITTEN
Monday, October 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 1, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 1, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 1, 2011NON-FINAL ACTION E-MAILED
Friday, April 1, 2011NON-FINAL ACTION WRITTEN
Thursday, February 24, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 18, 2011NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, February 3, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, February 3, 2011NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, January 21, 2011WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, January 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 8, 2011ASSIGNED TO LIE
Tuesday, December 14, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 9, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 9, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 9, 2010TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 29, 2010NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 29, 2010FINAL REFUSAL E-MAILED
Monday, November 29, 2010FINAL REFUSAL WRITTEN
Monday, October 25, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 24, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 24, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 24, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 24, 2010NON-FINAL ACTION E-MAILED
Saturday, April 24, 2010NON-FINAL ACTION WRITTEN
Tuesday, March 16, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 15, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 15, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 17, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 17, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 10, 2009REFUSAL PROCESSED BY IB
Wednesday, September 16, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 16, 2009REFUSAL PROCESSED BY MPU
Wednesday, September 16, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 15, 2009NON-FINAL ACTION WRITTEN
Saturday, September 12, 2009APPLICATION FILING RECEIPT MAILED
Tuesday, September 8, 2009ASSIGNED TO EXAMINER
Tuesday, September 8, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 4, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB